Although cholinergic losses in DLB affect both brainstem and basal forebrain presynaptic nuclei, in contrast to AD, postsynaptic cortical muscarinic and nicotinic receptors are more functionally intact,9 suggesting that cholinesterase inhibitors (ChEIs) may be potent for DLB. The gene discussed is BCHE; the disease is Lewy body dementia.